Synapse - Carol Aghajanian

Search Within

Carol A Aghajanian

Results (615)

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

Journal Article

Konner, J.; Schilder, R. J.; DeRosa, F. A.; Gerst, S. R.; Tew, W. P.; Sabbatini, P. J.; Hensley, M. L.; Spriggs, D. R.; Aghajanian, C. A.
Gynecologic Oncology (2008)

Fulltext@MSK | Save

A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission

Journal Article

Juretzka, M.; Hensley, M. L.; Tew, W.; Konner, J.; Aghajanian, C.; Leitao, M.; Iasonos, A.; Soslow, R.; Park, K.; Sabbatini, P.
European Journal of Gynaecological Oncology (2008)

Fulltext@MSK | Save

A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer

Journal Article

Hensley, M. L.; Larkin, J.; Fury, M.; Gerst, S.; Tai, D. F.; Sabbatini, P.; Konner, J.; Orlando, M.; Goss, T. L.; Aghajanian, C. A.
Clinical Cancer Research (2008)

Fulltext@MSK | Save

The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer

Journal Article

Eisenhauer, E. L.; Abu-Rustum, N. R.; Sonoda, Y.; Aghajanian, C.; Barakat, R. R.; Chi, D. S.
Gynecologic Oncology (2008)

Fulltext@MSK | Save

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission

Journal Article

Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
Clinical Cancer Research (2008)

Fulltext@MSK | Save

Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

Meeting Abstract

Schilder, R. J.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Pathak, H.; Aghajanian, C.; Drescher, C. W.; Godwin, A. K.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

The role of surgery in high-risk gestational trophoblastic disease patients

Meeting Abstract

Lewin, S. N.; Soslow, R. A.; Kim, M. J.; Derosa, F. A.; Abu-Rustum, N. R.; Sonoda, Y.; Brown, C. L.; Baines, M. S.; Flores, R.; Aghajanian, C. A.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I trial of PTK787/ZK222584 (PTK/ZK) in combination with carboplatin (C) and paclitaxel (T) in platinum-sensitive recurrent epithelial ovarian (EOC), fallopian tube (FT), or primary peritoneal (PPC) cancers

Meeting Abstract

Juretzka, M. M.; Aghajanian, C.; Hensley, M. L.; Tew, W. P.; Spriggs, D.; Konner, J.; Chiang, A. C.; Pezzulli, S.; Kim, M.; Sabbatini, P.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)

Meeting Abstract

Fury, M. G.; Larkin, J.; Gerst, S. R.; Sabbatini, P.; Konner, J.; Orlando, M.; Tai, D. F.; Goss, T.; Aghajanian, C.; Hensley, M. L.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save